
HFY-4A
CAS No. 2094810-82-7
HFY-4A( —— )
Catalog No. M37090 CAS No. 2094810-82-7
HFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 73 | In Stock |
![]() ![]() |
5MG | 103 | In Stock |
![]() ![]() |
10MG | 154 | In Stock |
![]() ![]() |
25MG | 247 | In Stock |
![]() ![]() |
50MG | 361 | In Stock |
![]() ![]() |
100MG | 601 | In Stock |
![]() ![]() |
500MG | 2115 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHFY-4A
-
NoteResearch use only, not for human use.
-
Brief DescriptionHFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.
-
DescriptionHFY-4A is a HDAC inhibitor. HFY-4A inhibits breast cancer cell proliferation, migration, and invasion, and induces cell apoptosis. HFY-4A induces immunogenic cell death (ICD). HFY-4A inhibits tumor growth in breast cancer xenograft mouse models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | HDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2094810-82-7
-
Formula Weight333.38
-
Molecular FormulaC20H19N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NCC1=CC=C(/C=C/C(NO)=O)C=C1)C2=NC3=C(C=C2)C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yin Y, et al. The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer. Toxicol Appl Pharmacol. 2023 Nov 1;478:116698.?
molnova catalog



related products
-
physalin F
Physalin F is a natural blocker of CaV2.3 (R-type) and CaV2.2 (N-type) voltage-gated calcium channels.It is a secosteroid with potent anti-inflammatory and immunomodulatory activities.
-
(R)-Isomucronulatol
(R)-Isomucronulatol (2H-1-Benzopyran-7-ol), a flavonoid that can be extracted from the leaves of Astragalus membranaceus, Sophora japonica, Sclerotium tigrinum, and Glycyrrhiza glabra, inhibits the proliferation and apoptosis of BMSCs in the TNF-α microenvironment.
-
Nimbolide
Nimbolide suppresses CDK4/CDK6 kinase activity. Nimbolide inhibits the NF-κB, Wnt, PI3K-Akt, MAPK, and JAK-STAT signaling pathways.